The current COVID19 pandemic showcases a critical need to accelerate the development and validation of quality diagnostic products for COVID-19. To support this effort, PATH, a global health non-profit has created a growing biorepository of qualified clinical samples to support and accelerate the development and validation of quality in-vitro diagnostics. The biorepository now includes convalescent plasma, creating more opportunities for affordable diagnostic development.
Click here to read more.